117 related articles for article (PubMed ID: 34083274)
21. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
22. CD74
Xiao N; Li K; Zhu X; Xu B; Liu X; Lei M; Sun HC
Cancer Immunol Immunother; 2022 Jan; 71(1):57-69. PubMed ID: 34009409
[TBL] [Abstract][Full Text] [Related]
23. Identification of an enriched CD4+ CD8alpha++ CD8beta+ T-cell subset among tumor-infiltrating lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Dal Cin P; Van den Berghe H; Ceuppens JL
Int J Cancer; 1997 Apr; 71(2):178-82. PubMed ID: 9139839
[TBL] [Abstract][Full Text] [Related]
24. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.
van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823
[TBL] [Abstract][Full Text] [Related]
25. Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue.
Sáenz-López P; Gouttefangeas C; Hennenlotter J; Concha A; Maleno I; Ruiz-Cabello F; Cózar JM; Tallada M; Stenzl A; Rammensee HG; Garrido F; Cabrera T
Tissue Antigens; 2010 Feb; 75(2):110-8. PubMed ID: 19912575
[TBL] [Abstract][Full Text] [Related]
26. Impaired proteolysis by SPPL2a causes CD74 fragment accumulation that can be recognized by anti-CD74 autoantibodies in human ankylosing spondylitis.
van Kempen TS; Leijten EFA; Lindenbergh MFS; Nordkamp MO; Driessen C; Lebbink RJ; Baerlecken N; Witte T; Radstake TRDJ; Boes M
Eur J Immunol; 2020 Aug; 50(8):1209-1219. PubMed ID: 32198923
[TBL] [Abstract][Full Text] [Related]
27. [Immunological study on renal cell carcinoma in dialysis patients with acquired cystic disease of kidneys].
Onishi T; Machida T; Masuda F; Torii S; Shirakawa H; Hatano T; Makino H
Nihon Hinyokika Gakkai Zasshi; 1991 Nov; 82(11):1800-6. PubMed ID: 1762269
[TBL] [Abstract][Full Text] [Related]
28. Peptidome from renal cell carcinoma contains antigens recognized by CD4+ T cells and shared among tumors of different histology.
Tassi E; Facchinetti V; Seresini S; Borri A; Dell'antonio G; Garavaglia C; Casorati G; Protti MP
Clin Cancer Res; 2006 Aug; 12(16):4949-57. PubMed ID: 16914584
[TBL] [Abstract][Full Text] [Related]
29. HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patients.
Janssen RA; Buter J; Straatsma E; Heijn AA; Sleijfer DT; de Vries EG; Mulder NH; The TH; de Leij L
Cancer Immunol Immunother; 1993; 36(3):198-204. PubMed ID: 8439981
[TBL] [Abstract][Full Text] [Related]
30. The Role of Autoimmunity-Related Gene
Rijvers L; Melief MJ; van Langelaar J; van der Vuurst de Vries RM; Wierenga-Wolf AF; Koetzier SC; Priatel JJ; Jorritsma T; van Ham SM; Hintzen RQ; van Luijn MM
J Immunol; 2020 Aug; 205(4):945-956. PubMed ID: 32641384
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of vascular endothelial growth factor-D expression in clear cell renal cell carcinoma by CD74: a critical role in cancer cell tumorigenesis.
Liu YH; Lin CY; Lin WC; Tang SW; Lai MK; Lin JY
J Immunol; 2008 Nov; 181(9):6584-94. PubMed ID: 18941249
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic markers in renal cell carcinoma.
Banner BF; Burnham JA; Bahnson RR; Ernstoff MS; Auerbach HE
Mod Pathol; 1990 Mar; 3(2):129-34. PubMed ID: 1691492
[TBL] [Abstract][Full Text] [Related]
33. CD74 and intratumoral immune response in breast cancer.
Wang ZQ; Milne K; Webb JR; Watson PH
Oncotarget; 2017 Feb; 8(8):12664-12674. PubMed ID: 27058619
[TBL] [Abstract][Full Text] [Related]
34. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
35. Characterization of HLA-G expression in renal cell carcinoma.
Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
[TBL] [Abstract][Full Text] [Related]
36. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.
Fujii S; Senju S; Chen YZ; Ando M; Matsushita S; Nishimura Y
Hum Immunol; 1998 Oct; 59(10):607-14. PubMed ID: 9757942
[TBL] [Abstract][Full Text] [Related]
37. Invariant chain expression in gastric cancer.
Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Iwashige H; Aridome K; Hokita S; Aikou T
Cancer Lett; 2001 Jul; 168(1):87-91. PubMed ID: 11368882
[TBL] [Abstract][Full Text] [Related]
38. HIV-mediated up-regulation of invariant chain (CD74) correlates with generalized immune activation in HIV+ subjects.
Ghiglione Y; Rodríguez AM; De Candia C; Carobene M; Benaroch P; Schindler M; Salomón H; Turk G
Virus Res; 2012 Jan; 163(1):380-4. PubMed ID: 21945129
[TBL] [Abstract][Full Text] [Related]
39. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
[TBL] [Abstract][Full Text] [Related]
40. Structure, expression and function of HLA-G in renal cell carcinoma.
Seliger B; Schlaf G
Semin Cancer Biol; 2007 Dec; 17(6):444-50. PubMed ID: 17707652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
